SCHEMBL4317428

SCHEMBL4317428

NC(Cc1ccccc1)(c1ccccc1)P(=O)(O)O

nearest known ligand 0.58

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
FDPS P14324 1/20 0.58
PTPN1 P18031 7/20 0.53
PGK1 P00558 2/20 0.50
PGK2 P07205 2/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
HIF1A Q16665 1/20 0.50
CYP1A2 P05177 1/20 0.48
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48
PTPN5 P54829 1/20 0.47
PTPRC P08575 1/20 0.46
SLC6A2 P23975 1/20 0.45
TAAR1 Q96RJ0 1/20 0.45
KIF11 P52732 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4093885 0.80 FDPS (0.62) FDPSPTPN1SMN1; SMN2HIF1ASLC6A2
SCHEMBL8146934 0.80 PTPN1 (0.57) FDPSPTPN1PGK1PGK2PTPN5
SCHEMBL11403925 0.78 FDPS (0.60) FDPSPTPN1PGK1PGK2SMN1; SMN2
SCHEMBL82460 0.75 CYP1A2 (0.61) FDPSSMN1; SMN2HIF1ACYP1A2CYP2C9
SCHEMBL2067595 0.75 CYP1A2 (0.61) FDPSSMN1; SMN2HIF1ACYP1A2CYP2C9
SCHEMBL2067126 0.75 CYP1A2 (0.61) FDPSSMN1; SMN2HIF1ACYP1A2CYP2C9
SCHEMBL7264380 0.75 FDPS (0.67) FDPSPTPN1SMN1; SMN2HIF1ACYP1A2
SCHEMBL3075655 0.75 FDPS (0.67) FDPSPTPN1SMN1; SMN2HIF1ACYP1A2
SCHEMBL7606373 0.74 FDPS (0.70) FDPSPTPN1SMN1; SMN2HIF1ACYP1A2
SCHEMBL3846830 0.74 FDPS (1.00) FDPSCYP1A2CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3681504-B1 METHODS OF DETECTION USING X-RAY FLUORESCENCE ICAGEN INC (US) 2023-08-23 EP disclosed
US-11573224-B2 Methods of detection using X-ray fluorescence ICAGEN, LLC (US) 2023-02-07 US disclosed
US-11446398-B2 Regulated biocircuit systems OBSIDIAN THERAPEUTICS, INC. (US) 2022-09-20 US disclosed
US-20210254056-A1 IDENTIFICATION AND TARGETED MODULATION OF GENE SIGNALING NETWORKS CAMP4 THERAPEUTICS CORPORATION 2021-08-19 US disclosed
US-10877035-B2 Advanced drug development and manufacturing ICAGEN, LLC (US) 2020-12-29 US disclosed
US-20200278346-A1 METHODS OF DETECTION USING X-RAY FLUORESCENCE ADJACENT ACQUISITION CO., LLC 2020-09-03 US disclosed
EP-3681504-A1 METHODS OF DETECTION USING X-RAY FLUORESCENCE Icagen, Inc. (US) 2020-07-22 EP disclosed
US-20190192691-A1 REGULATED BIOCIRCUIT SYSTEMS OBSIDIAN THERAPEUTICS, INC. 2019-06-27 US disclosed
WO-2019055754-A1 METHODS OF DETECTION USING X-RAY FLUORESCENCE ICAGEN, INC. (US) 2019-03-21 WO disclosed
US-20150309021-A1 Advanced Drug Development and Manufacturing LOS ALAMOS NATIONAL SECURITY, LLC 2015-10-29 US disclosed
EP-2511844-B1 X-ray microscope XRPRO SCIENCES INC (US) 2015-08-12 EP disclosed
EP-2511844-A2 Advanced drug development and manufacturing Los Alamos National Security, LLC (US) 2012-10-17 EP disclosed
EP-2084519-B1 X-RAY FLUORESCENCE ANALYSIS METHOD LOS ALAMOS NAT SECURITY LLC (US) 2012-08-01 EP disclosed
EP-2084519-A2 ADVANCED DRUG DEVELOPMENT AND MANUFACTURING Los Alamos National Security, LLC (US) 2009-08-05 EP disclosed
WO-2008127291-A2 ADVANCED DRUG DEVELOPMENT AND MANUFACTURING LOS ALAMOS NATIONAL SECURITY, LLC (US) 2008-10-23 WO disclosed
US-20080220441-A1 Advanced drug development and manufacturing THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2008-09-11 US disclosed